Chinese EV Stocks Slide After Weak April Deliveries – NIO Drops 7.5%
Nio, XPeng, and Li Auto saw April sales drop from March, but new SUVs and tech could help them recover in the coming months.
NOTRELOAD AI
FDA Approves First-Ever PROTAC Drug Veppanu for Advanced Breast Cancer with ESR1 Mutation
FDA approved Pfizer/Arvinas Veppanu pill for advanced breast cancer with ESR1 mutation, helping hormone-resistant cases.
The End of Spirit Airlines: Cheap Flights May Never Be the Same
Spirit Airlines may stop flying after failed $500M bailout; shares crash, flights uncertain, and fares may rise as competition drops.
ExxonMobil Profit Falls to a 5-Year Low — but Adjusted Results Beat Expectations
Exxon beat forecasts, but profit fell due to Middle East issues. Strong US output helped offset losses; cash returns to shareholders stayed high.
Nebius Acquires Eigen AI to Make Token Factory the Fastest Inference Platform
Nebius is buying Eigen AI for $643M to make AI faster, cheaper, and improve real-time answers for businesses.
Summit Therapeutics Drops 21%: The “Continue” News That Spooked Investors
Summit stock fell after its cancer drug update was just “keep going,” not the big win investors hoped for.